Palisaded neutrophilic and granulomatous dermatitis associated with ledipasvir/sofosbuvir
- PMID: 30246134
- PMCID: PMC6141673
- DOI: 10.1016/j.jdcr.2018.06.025
Palisaded neutrophilic and granulomatous dermatitis associated with ledipasvir/sofosbuvir
Keywords: GA, granuloma annulare; HCV, hepatitis C virus; INF, interferon; LDV/SOF, ledipasvir/sofosbuvir; PNGD, palisaded neutrophilic and granulomatous dermatitis; drug reaction; granulomatous dermatitis; hepatitis C; ledipasvir/sofosbuvir; palisaded neutrophilic and granulomatous dermatitis.
Figures
References
-
- Rosenbach M., English J.C., 3rd Reactive granulomatous dermatitis: a review of palisaded neutrophilic and granulomatous dermatitis, interstitial granulomatous dermatitis, interstitial granulomatous drug reaction, and a proposed reclassification. Dermatol Clin. 2015;33(3):373–387. - PubMed
-
- Johnson S.W., Ammirati S.R., Hartis C.E. Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach. Int J Antimicrob Agents. 2017;49(6):778–781. - PubMed
-
- Afdhal N., Zeuzem S., Kwo P. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Eng J Med. 2014;370(20):1889–1898. - PubMed
-
- Gordon K., Miteva M., Torchia D., Romanelli P. Allopurinol-induced palisaded neutrophilic and granulomatous dermatitis. Cutan Ocul Toxicol. 2012;31(4):338–340. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources